(Date:12/2/2008)... form an integral part of most of,original equipm...ore become,essential for service providers in the...in competitive and constantly improve their servic...: http://www.newscom.com/cgi-bin/prnh/20081117/F...livan ( http://www.medicalimaging.frost.com ),Eur...
(Date:12/2/2008)...ctation Service, one of the premier leaders in med...egal dictation transcription, has joined up with ...organization geared to the betterment of women and...ughout Lower Westchester County, New York. , ..., 2008 -- World Wide Dictation Services of New Yor...
(Date:12/2/2008)...s ASHP midyear meeting, FFF Enterprises, the natio...al-care biopharmaceuticals and vaccines, will unve...rity and demonstrate how the company has taken pha...439) , (Vocus) December 2... Enterprises, the nation,s largest and most truste...
(Date:12/2/2008)...lies, the problem with the holidays is family. El...how caregivers of aging parents can bring the joy .... , San Mateo, CA (PRWEB)...of the holiday season is family, especially aging ...her Koch , founder of Encore Management , has a s...
Breaking Medicine News(10 mins):Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 3Health News:World Wide Dictation Service Teams up with TMATT for Local Thanksgiving Community Dinner 2Health News:FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando 2Health News:FFF Enterprises Unveils ‘The 8 Critical Steps to Guaranteed Channel Integrity' at the American Society of Health-System Pharmacists (ASHP) Midyear Meeting in Orlando 3Health News:Holidays with Aging Parents: Elder Care Expert Has the Prescription for Caregiver Stress 2Health News:Holidays with Aging Parents: Elder Care Expert Has the Prescription for Caregiver Stress 3(Date:12/1/2008)...EGO, Dec. 1 Vical Incorp...pt of a $1.0 million milestone payment from Merck ...n of a Phase I clinical trial of an investigationa... vaccine is based on Vical,s DNA gene delivery tec...criptase (hTERT). hTERT is the subject of separate...
(Date:11/27/2008)...udy finds the majority of acute lymphoblastic leuk...nt at the time of diagnosis , , MEMPHIS, Te... at St. Jude Children,s Research Hospital have ide...cells of children with acute lymphoblastic leukemi...athway to designing treatments for ALL relapse in ...
(Date:11/25/2008)...ILLE, Ky., Nov. 25 Klei...eons performed the fifth U.S. hand transplant on M... Louisville,s Jewish Hospital Hand Care Center on ...an around noon and was completed shortly after 9 p...ttp://www.newscom.com/cgi-bin/prnh/20081125/DC4855...
(Date:11/25/2008)...tients Enrolled in Clinical Trial to Assess Surviv...are Therapies for Unresectable Hepatocellular Carc...ire/ -- Light Sciences Oncology, Inc. (LSO) today ... Phase 3 clinical trial of Light Infusion Therapy(...atocellular carcinoma (HCC), also known as hepatom...
Breaking Medicine Technology:Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Dynatronics Announces 24250 000 Increase in Stock Buyback Program 7510 1Dynatronics Announces 24250 000 Increase in Stock Buyback Program 7510 2In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 1In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 2In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 3In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 4In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 5In the Forefront of Research into Protein Folding and Macromolecular Complex Assembly 7505 6Exercising our immune system 7500 1Exercising our immune system 7500 23 Common Drugs Trigger Most ER Visits by Seniors 7496 13 Common Drugs Trigger Most ER Visits by Seniors 7496 2...re-FirstCall/ Haemacure,Corporation , a Montreal-b...unced the preliminary findings of the content anal...findings confirm the presence of a number of,prote...orldwide,markets, including albumin, plasminogen, ...a strategic significance for Haemacure as,revenues...
...-FirstCall/ --,Bristol-Myers Squibb Company today ...y of ORENCIA(R) (abatacept) from the open-label,ph...n with juvenile,idiopathic arthritis (JIA) who hav...e-modifying anti- rheumatic drugs (DMARDs), such,a...) antagonists.,The results demonstrated that, afte...
Other Medicine Technology:Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 2Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 3Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 4Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 2Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 3Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 4Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 5Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 6...t Lamp is the ideal instrument combination: in nex...to an indirect ophthalmoscope. ,Convenient and ... posterior ocular segments, the HSO 10 Hand Slit L...utstanding benefits for your work include the exce...
The unparalleled Humphrey Lens Analyzers Model 350 and Model 360 with SPEXAN provide the most comprehensive lensometry for your practice. ,Simple to operate, the Humphrey Lens Analyzer (LA) gives f
Lens Loading and Folding for Multipiece & Single-Piece ACRYSOF Lens with Standard Forceps
... is a hospital grade Nd: YAG laser photodisruptor ...se, reliable means for performing posterior capsul... system can be used for the treatment of secondary...ior capsulotomy), and closed-angle glaucoma (irido...
Medicine Products: